Table 1 The main demographic, clinical, and pathological characteristics of the 243 patients with CESC
From: Comprehensive analysis of prognostic alternative splicing signature in cervical cancer
Characteristic | Survival (n = 187) | Death (n = 56) | P value* |
|---|---|---|---|
Age (years) | |||
 ≤ 60 | 163 (87.2) | 42 (75.0) | 0.047 |
 > 60 | 24 (12.8) | 14 (25.0) |  |
Race | |||
  White | 132 (70.6) | 41 (73.2) | 0.473 |
  Black or African American | 20 (10.7) | 7 (12.5) |  |
  Asian | 16 (8.6) | 1 (1.8) |  |
  Other | 6 (3.2) | 3 (5.4) |  |
  NA | 13 (7.0) | 4 (7.1) |  |
Histological type | |||
  Adenosquamous | 4 (2.1) | 1 (1.8) |  |
  Cervical squamous cell carcinoma | 157 (84.0) | 49 (87.5) |  |
  Endocervical adenocarcinoma | 26 (13.9) | 6 (10.7) |  |
 AJCC stage | |||
  Stage I | 113 (60.4) | 34 (60.7) | 0.002 |
  Stage II | 41 (21.9) | 6 (10.7) |  |
  Stage III | 24 (12.8) | 8 (14.3) |  |
  Stage IV | 4 (2.1) | 8 (14.3) |  |
  NA | 5 (2.7) | 0 (0.0) |  |
 Grade | |||
  G1 | 14 (7.5) | 1 (1.8) | 0.342 |
  G2 | 78 (41.7) | 29 (51.8) |  |
  G3 | 80 (42.8) | 19 (33.9) |  |
  G4 | 1 (0.5) | 0 (0.0) |  |
  GX | 14 (7.5) | 7 (12.5) |  |